Soomets U - Search Results

1

Structural determinants for binding to CGRP receptors expressed by human SK-N-MC and Col 29 cells: studies with chimeric and other peptides.

Poyner DR, Soomets U, Howitt SG, Langel U. Poyner DR, et al. Among authors: soomets u. Br J Pharmacol. 1998 Aug;124(8):1659-66. doi: 10.1038/sj.bjp.0702032. Br J Pharmacol. 1998. PMID: 9756381 Free PMC article.

2

Biochemical mechanisms of calcium mobilisation induced by mastoparan and chimeric hormone-mastoparan constructs.

Longland CL, Mezna M, Langel U, Hällbrink M, Soomets U, Wheatley M, Michelangeli F, Howl J. Longland CL, et al. Among authors: soomets u. Cell Calcium. 1998 Jul;24(1):27-34. doi: 10.1016/s0143-4160(98)90086-0. Cell Calcium. 1998. PMID: 9793686

3

Novel mastoparan analogs induce differential secretion from mast cells.

Farquhar M, Soomets U, Bates RL, Martin A, Langel U, Howl J. Farquhar M, et al. Among authors: soomets u. Chem Biol. 2002 Jan;9(1):63-70. doi: 10.1016/s1074-5521(01)00098-9. Chem Biol. 2002. PMID: 11841939

4

Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo.

Pooga M, Soomets U, Hällbrink M, Valkna A, Saar K, Rezaei K, Kahl U, Hao JX, Xu XJ, Wiesenfeld-Hallin Z, Hökfelt T, Bartfai T, Langel U. Pooga M, et al. Among authors: soomets u. Nat Biotechnol. 1998 Sep;16(9):857-61. doi: 10.1038/nbt0998-857. Nat Biotechnol. 1998. PMID: 9743120

5

Effects of vasopressin-mastoparan chimeric peptides on insulin release and G-protein activity.

Hällbrink M, Saar K, Ostenson CG, Soomets U, Efendic S, Howl J, Wheatley M, Zorko M, Langel U. Hällbrink M, et al. Among authors: soomets u. Regul Pept. 1999 Jun 30;82(1-3):45-51. doi: 10.1016/s0167-0115(99)00034-8. Regul Pept. 1999. PMID: 10458645

6

Translocation properties of novel cell penetrating transportan and penetratin analogues.

Lindgren M, Gallet X, Soomets U, Hällbrink M, Bråkenhielm E, Pooga M, Brasseur R, Langel U. Lindgren M, et al. Among authors: soomets u. Bioconjug Chem. 2000 Sep-Oct;11(5):619-26. doi: 10.1021/bc990156s. Bioconjug Chem. 2000. PMID: 10995204

7

Electrophysiological evidence for a hyperpolarizing, galanin (1-15)-selective receptor on hippocampal CA3 pyramidal neurons.

Xu ZQ, Ma X, Soomets U, Langel U, Hökfelt T. Xu ZQ, et al. Among authors: soomets u. Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14583-7. doi: 10.1073/pnas.96.25.14583. Proc Natl Acad Sci U S A. 1999. PMID: 10588748 Free PMC article.

8

Targeting of antisense PNA oligomers to human galanin receptor type 1 mRNA.

Kilk K, Elmquist A, Saar K, Pooga M, Land T, Bartfai T, Soomets U, Langel U. Kilk K, et al. Among authors: soomets u. Neuropeptides. 2004 Oct;38(5):316-24. doi: 10.1016/j.npep.2004.06.005. Neuropeptides. 2004. PMID: 15464198

9

Anticonvulsant activity of a nonpeptide galanin receptor agonist.

Saar K, Mazarati AM, Mahlapuu R, Hallnemo G, Soomets U, Kilk K, Hellberg S, Pooga M, Tolf BR, Shi TS, Hökfelt T, Wasterlain C, Bartfai T, Langel U. Saar K, et al. Among authors: soomets u. Proc Natl Acad Sci U S A. 2002 May 14;99(10):7136-41. doi: 10.1073/pnas.102163499. Proc Natl Acad Sci U S A. 2002. PMID: 12011470 Free PMC article.

10

Down-regulation of amyloid precursor protein by peptide nucleic acid oligomer in cultured rat primary neurons and astrocytes.

Adlerz L, Soomets U, Holmlund L, Viirlaid S, Langel U, Iverfeldt K. Adlerz L, et al. Among authors: soomets u. Neurosci Lett. 2003 Jan 9;336(1):55-9. doi: 10.1016/s0304-3940(02)01219-3. Neurosci Lett. 2003. PMID: 12493601

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results